Abstract
Hepatic carcinoid tumors are very uncommon; most are clinically non-functional and very few present with the symptoms of carcinoid syndrome. ACTH-producing carcinoid tumors most commonly originate in the lung or thymus and present insidiously with bronchospasm and/or chest mass. Occasionally, ectopic ACTH syndromes have been reported in association with pancreatic islet cell tumors, medullary thyroid cancer, pheochromocytoma, small-cell lung carcinoma, and rarely, ovarian and prostate tumors. We report here a patient with an ectopic ACTH-secreting primary hepatic carcinoid tumor who presented with cushingoid appearance, profound proximal muscle weakness, severe lower extremity edema, and markedly elevated urinary free cortisol. ACTH levels were in the low normal range. A solitary vascular hepatic lesion was found on magnetic resonance imaging, which was isodense with the surrounding liver on octreotide scan and photopenic on an 18-fluorodeoxyglucose (18FDG)-positron emission tomography (PET) scan. Following surgical resection of the hepatic tumor, histopathology confirmed an ACTH-secreting neuroendocrine tumor (NET), the patient had complete resolution of hypercortisolemic symptoms and remains in remission, now 4 yr after hepatic tumor resection. This case reports the first ACTH-secreting primary hepatic NET presenting as ectopic Cushing’s syndrome. Interesting aspects of this case include the presence of a pituitary incidentaloma, the low normal ACTH, and photopenia on 18FDG-PET imaging.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fenwick SW, Wyatt JI, Toogood GJ, Lodge JP. Hepatic resection and transplantation for primary carcinoid tumors of the liver. Ann Surg 2004, 239: 210–9.
Caplin ME, Buscombe JR, Hilson AJ, Jones AL, Watkinson AF, Burroughs AK. Carcinoid tumour. Lancet 1998, 352: 799–805.
Ganim RB, Norton JA. Recent advances in carcinoid pathogenesis, diagnosis and management. Surg Oncol 2000, 9: 173–9.
Vinik AI, McLeod MK, Fig LM, Shapiro B, Lloyd RV, Cho K. Clinical features, diagnosis, and localization of carcinoid tumors and their management. Gastroenterol Clin North Am 1989, 18: 865–96.
Solcia E, Kloppel G, Sobin LH. Histopathological typing of endocrine tumours. Second Edition. WHO International Histological Classification of tumour. Berlin: Springer, 2000.
Iwao M, Nakamuta M, Enjoji M, et al. Primary hepatic carcinoid tumor: case report and review of 53 cases. Med Sci Monit 2001, 7: 746–50.
Maire F, Couvelard A, Vullierme MP, et al. Primary endocrine tumours of the liver. Br J Surg 2005, 92: 1255–60.
Wajchenberg BL, Mendonca BB, Liberman B, et al. Ectopic adrenocorticotropic hormone syndrome. Endocr Rev 1994, 15: 752–87.
Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 1998, 19: 647–72.
Aniszewski JP, Young WF Jr, Thompson GB, Grant CS, van Heerden JA. Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg 2001, 25: 934–40.
Lamberts SW, Bakker WH, Reubi JC, Krenning EP. Somatostatin-receptor imaging in the localization of endocrine tumors. N Eng J Med 1990, 323: 1246–9.
Shrager JB, Wright CD, Wain JC, Torchiana DF, Grillo HC, Mathisen DJ. Bronchopulmonory carcinoid tumors associated with Cushing’s syndrome: a more aggressive variant of typical carcinoid. J Thorac Cardiovas Surg 1997, 114: 367–75.
Alpert LI, Zak FG, Werthamer S, Bochetto JF. Cholangiocarcinoma: a clincicopathological study of five cases with ultrastructural observation. Hum Pathol 1974, 5: 709–28.
Hsueh C, Tan XD, Gonzalez-Crussi F. Primary hepatic neuroendocrine carcinoma in a child. Morphological, immunocytochemical, and molecular biological studies. Cancer 1993, 71: 2600–5.
Howlett TA, Drury PL, Perry L, Doniach I, Ress LH, Besser GM. Diagnosis and management of ACTH-dependent Cushing’s syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf)1986, 24: 699–71
Oliver RL, Davis JR, White A. Characterization of ACTH related peptides in ectopic Cushing’s syndrome. Pituitary 2003, 6: 119–26.
Tabarin A, Corcuff JB, Rashedi M, Navarranne A, Ducassou D, Roger P. Comparative value of plasma ACTH and beta-endorphin measurement with three different commercial kits for the etiological diagnosis of ACTH-dependent Cushing’s syndrome. Acta Endocrinol (Copenh) 1992, 126: 308–14.
Vieau D, Massias JF, Girard F, Luton JP, Bertagna X. Corticotropin-like intermediary lobe peptide as a marker of alternate pro-opiomelanocortin processing in ACTH-producing non-pituitary tumours. Clin Endocrinol (Oxf) 1989, 31: 691–700.
Vieau D, Seidah NG, Mbikay M, Chretien M, Bertagna X. Expression of the prohormone convertase PC2 correlates with the presence of corticotropin-like intermediate lobe peptide in human adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab 1994, 79: 1503–6.
Odell WD. Bronchial and thymic carcinoids and the ectopic ACTH syndrome. Ann Thorac Surg 1990, 50: 5–6.
Oldfield EH, Doppman JL, Nieman LK, et al. Petrosal sinus sampling with and without corticotrophin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med 1991, 325: 897–905.
Becker M, Aron DC. Ectopic ACTH syndrome and CRH-mediated Cushing’s syndrome. Endocrinol Metab Clin North Am 1994, 23: 585–606.
Molitch ME, Russell EJ. The pituitary “incidentaloma”. Ann Intern Med 1990, 112: 925–31.
Torpy DJ, Chen CC, Mullen N, et al. Lack of utility of 111Inpentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients. J Clin Endocrinol Metab 1999, 84: 1186–92.
Pacak K, Ilias I, Chen CC, Carrasquillo JA, Whatley M, Nieman LK. The role of 18F-fluorodeoxyglucose positron emission tomography and 111In-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushings’s syndrome. J Clin Endocrinol Metab, 2004, 89: 2214–21.
Rubello D, Rufini V, Casara D, Calcagni ML, Samanes Gajate AM, Shapiro B. Clinical role of Positron Emission Tomography (PET) in endocrine tumours. Panminerva Med 2002, 44: 185–96.
Erikson B, Orlefors H, Oberg K, Sundin A, Bergstrom M, Langstrom B. Developments in PET for the detection of endocrine tumours. Best Pract Res Clin Endocrinol Metab 2005, 19: 311–24.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shah, N.A., Urusova, I.A., D’Agnolo, A. et al. Primary hepatic carcinoid tumor presenting as Cushing’s syndrome. J Endocrinol Invest 30, 327–333 (2007). https://doi.org/10.1007/BF03346308
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346308